KROS   $14.26  -4.23% Market Open

Keros Therapeutics Inc
Total Cash 405.86M
totalCashPerShare 10.817
EBITDA -187.62M
Total Debt 13.96M
quickRatio 19.167
currentRatio 20.368
Total Revenue 271.00K
debtToEquity 3.316
Revenue/Share 0.008
ROA -0.29066
ROE -0.44984
grossProfits
freeCashflow -96.84M
operatingCashflow -143.80M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins -1363.2163
profitMargins 0.0
enterpriseValue 1.96B
forwardPE -12.237569
floatShares 32.39M
sharesOutstanding 37.52M
sharesShort 2.72M
sharesShortPriorMonth 3.50M
dateShortInterest
sharesPercentSharesOut 0.07%
heldPercentInsiders 0.06%
heldPercentInstitutions 1.00%
Short Ratio help_outline 7.71%
shortPercentOfFloat 0.10%
impliedSharesOutstanding
bookValue 11.637
Price To Book help_outline 5.71
earningsQuarterlyGrowth
netIncomeToCommon -168.05M
trailingEps -5.13%
forwardEps -5.43%
enterpriseToEbitda -10.43
lastDividendValue
lastDividendDate
currentQuarterEstimate -1.28 3Q 2024
institutionsCount 227
lastUpdated Nov. 7, 2024, 3:13 a.m.